Three-Year NHS Study Shows Blood Test Reduces Stage IV Cancer Diagnoses
The Galleri blood test demonstrated a four-fold increase in cancer detection rates and substantial reduction in stage IV cancer diagnoses in 142,000 participants.
Category: Cancer
Cancer
Latest
Cancer
Latest
GRAIL Submits FDA Application for Multi-Cancer Early Detection Test
GRAIL has submitted an FDA premarket approval application for its Galleri multi-cancer early detection test, supported by data from more than 25,000 participants in US and UK clinical trials.
Cancer
Latest
Lucid Diagnostics Secures VA Contract for Esophageal DNA Test
Lucid Diagnostics has secured a VA contract for its EsoGuard Esophageal DNA Test, expanding access to esophageal precancer screening for more than 9 million veterans through the federal supply schedule at Medicare-aligned pricing.
InterVenn Partners with Aranscia to Expand Ovarian Cancer Test Access
Multi-year agreement will provide clinical workflow software and laboratory support for GlycoKnow liquid biopsy test.
Read More
HRSA Updates Cervical Cancer Screening Guidelines to Include Self-Collection
New guidelines designate high-risk HPV testing as preferred screening method for women ages 30-65 and require insurance coverage for additional testing.
Read More
Human Longevity Expands $1M Cancer Pledge to Include Colon Cancer
The biotechnology company’s integrated screening approach combines whole-genome sequencing, imaging, and multiple biomarker tests to enable early detection.
Read More
PreciseDx Presents Validation Data for AI Breast Cancer Recurrence Test
Three abstracts showcase PreciseBreast’s ability to predict recurrence risk in early-stage invasive breast cancer using digital pathology.
Read More
Why Cervical Cancer Screening Rates Are Falling—and What Could Help Reverse the Trend
Despite effective prevention tools, Millennials are delaying screening. New approaches may help remove barriers to participation.
Read More
AI Pathology Solution Shows Concordance with Pathologists in HER2 Interpretation for Biliary Tract Cancer
Study in biliary tract cancer finds the solution achieved 83.5% overall concordance rate with expert interpretations.
Read More
CTC Counts Show Value in Guiding Metastatic Breast Cancer Treatment Decisions
Researchers found that circulating tumor cell counts stratified patients by disease aggressiveness and were associated with differing outcomes following endocrine versus combination therapy.
Read More
Genomic Test Shows Promise for Identifying High-Risk Prostate Cancer in African American Men
A genomic test widely used in prostate cancer care can more accurately identify which men with early-stage disease face high risk of recurrence after treatment.
Read More
Reducing the Cost of Cancer Care with Improved Diagnostics
Better cancer testing can help patients avoid unnecessary scans and biopsies, while also lowering costs for the healthcare system.
Read More
Yenos Analytical Launches Multi-Cancer Early Detection Urine Test
The direct-to-consumer laboratory-developed test detects six cancer types with 97% sensitivity and specificity using microRNA biomarkers, according to the company.
Read More
Blood Test Shows Chemotherapy Response in Glioblastoma After First Treatment Dose
New diagnostic chip pulls packets released from tumor cells out of blood, showing whether cancer cells died during chemotherapy infusion.
Read More
Studies Find Merlin CP-GEP Test Improved Melanoma Risk Stratification
Two peer-reviewed studies demonstrate superior risk stratification compared to traditional clinicopathologic features and competitor testing.
Read More
Roche Gains FDA Approval for Expanded HER2 Diagnostic Test Indications
The test can now be used to identify HER2-positive metastatic breast cancer patients that could be eligible for Enhertu.
Read More
Test Validated to Predict Recurrence Risk and Radiation Therapy Benefit in Breast Cancer
A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.
Read More
Cell-Free DNA Test May Identify Immunotherapy Adverse Events Earlier
Johns Hopkins researchers found the blood test detected multiorgan tissue damage in patients experiencing immune-related adverse events from checkpoint inhibitor therapy.
Read More
- 1
- ...
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- ...
- 190